Article Name Europe
Mosaic 3D represents the next generation of non-ablative fractional laser, offering to deliver more energy and cover more areas
02nd February, 2026
The Company expects to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months
30th January, 2026
This helps endoscopists stay focused on true findings, with fewer distractions on the screen and less time spent investigating non-lesions
27th January, 2026
The benefits of this in-house lab are clear, especially for people coming from other countries for dental care
23rd January, 2026
ARC-BCI is the world’s first and most advanced purpose-designed platform pairing a brain-computer interface with an implantable spinal cord stimulation system
22nd January, 2026
Report Emphasises the Importance of Home Support in Alleviating Hospital Pressures and Supporting the Ageing Population
21st January, 2026
Enables convenient on-body delivery of higher dose therapies like anti-cancer treatments and monoclonal antibodies
19th January, 2026
Builds an integrated global commercialisation platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide
16th January, 2026
This strategic transaction marks a key milestone in the development of Affidea Switzerland
15th January, 2026
The investment - which is a substantial contribution from Verdane's €2 billion growth fund - is the single largest investment in Clue
15th January, 2026
Over 300 million electrocardiograms (ECGs) are performed annually worldwide
13th January, 2026
Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery
08th January, 2026
203 patients were randomised to receive either endocrine monotherapy or combination therapy consisting of a doublet (endocrine therapy plus a CDK4/6 inhibitor)
02nd January, 2026
This acquisition complements IBA’s existing nuclear medicine strategic initiatives, including the co-founding of PanTera for the production of Ac-225, and the shaping of the Accelerate
19th December, 2025
First Genio implants successfully performed at OLVG West and Zuyderland hospitals
17th December, 2025
The ProVee System is a next-generation prostatic urethral stent designed to gently open up the obstructed prostate and relieve lower urinary tract symptoms associated with BPH
10th December, 2025
This release introduces hardware and software enhancements designed to improve workflow efficiency and system performance
10th December, 2025
The service can also be scaled to meet rising volumes and support expansion into additional imaging specialities
09th December, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer